EA202092016A1 - IMIDAZOPYRIMIDINES AND TRIAZOLOPYRIMIDINES AS A2A / A2B INHIBITORS - Google Patents
IMIDAZOPYRIMIDINES AND TRIAZOLOPYRIMIDINES AS A2A / A2B INHIBITORSInfo
- Publication number
- EA202092016A1 EA202092016A1 EA202092016A EA202092016A EA202092016A1 EA 202092016 A1 EA202092016 A1 EA 202092016A1 EA 202092016 A EA202092016 A EA 202092016A EA 202092016 A EA202092016 A EA 202092016A EA 202092016 A1 EA202092016 A1 EA 202092016A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- diseases
- imidazopyrimidines
- triazolopyrimidines
- inhibitors
- activity
- Prior art date
Links
Landscapes
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Данная заявка относится к соединениям формулы (I)или их фармацевтически приемлемым солям или стереоизомерам, которые модулируют активность аденозиновых рецепторов, таких как подтипы A2A и A2B рецепторов, и пригодны при лечении заболеваний, связанных с активностью аденозиновых рецепторов, включая, например, рак, воспалительные заболевания, сердечно-сосудистые заболевания, болезни и нейродегенеративные заболевания.This application relates to compounds of formula (I), or pharmaceutically acceptable salts or stereoisomers thereof, which modulate the activity of adenosine receptors, such as the A2A and A2B receptor subtypes, and are useful in the treatment of diseases associated with adenosine receptor activity, including, for example, cancer, inflammatory diseases, cardiovascular diseases, diseases and neurodegenerative diseases.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962793015P | 2019-01-16 | 2019-01-16 | |
| PCT/US2019/019582 WO2019168847A1 (en) | 2018-02-27 | 2019-02-26 | Imidazopyrimidines and triazolopyrimidines as a2a / a2b inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EA202092016A1 true EA202092016A1 (en) | 2021-01-29 |
Family
ID=74222460
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA202092016A EA202092016A1 (en) | 2019-01-16 | 2019-02-26 | IMIDAZOPYRIMIDINES AND TRIAZOLOPYRIMIDINES AS A2A / A2B INHIBITORS |
Country Status (1)
| Country | Link |
|---|---|
| EA (1) | EA202092016A1 (en) |
-
2019
- 2019-02-26 EA EA202092016A patent/EA202092016A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2022014648A (en) | Imidazopyrimidines and triazolopyrimidines as a2a / a2b inhibitors. | |
| MX2023008994A (en) | Fused pyrazine derivatives as a2a / a2b inhibitors. | |
| MX2020012376A (en) | Fused pyrimidine derivatives as a2a / a2b inhibitors. | |
| EA202192093A1 (en) | PYRAZOLOPYRIDINES AND TRIAZOLOPYRIDINES AS A2A / A2B INHIBITORS | |
| CY1123756T1 (en) | DIPYRAZOLE DERIVATIVES AS JAK INHIBITORS | |
| MX2023000410A (en) | Rapamycin analogs as mtor inhibitors. | |
| MX2022002219A (en) | Triazolopyrimidines as a2a / a2b inhibitors. | |
| EA201891191A1 (en) | 2-SUBSTITUTED HINAZOLIN COMPOUNDS CONTAINING A SUBSTITUTED HETEROCYCLIC GROUP AND METHODS OF THEIR APPLICATION | |
| EA201790078A1 (en) | MNK INHIBITORS AND RELATED METHODS | |
| UY35470A (en) | 3-PIRIMIDIN-4-IL-OXAZOLIDIN-2-ONAS AS MUTANT HDI INHIBITORS | |
| EA201591753A1 (en) | 3-PYRIMIDIN-4-ILOXAZOLIDIN-2-ONE AS MUTANT IDH INHIBITORS | |
| TR201909997T4 (en) | Amide compounds as 5-HT4 receptor agonists. | |
| EA202092016A1 (en) | IMIDAZOPYRIMIDINES AND TRIAZOLOPYRIMIDINES AS A2A / A2B INHIBITORS | |
| EA202190204A1 (en) | CONDENSED PYRAZINE DERIVATIVES AS A2A / A2B INHIBITORS | |
| EA202191738A1 (en) | COMPOUNDS OF IMIDAZOPYRIDAZINE AND IMIDAZOPYRIDINE AND THEIR APPLICATION | |
| EA202092600A1 (en) | TETRACYCLIC HETEROARYL COMPOUNDS | |
| MY192305A (en) | Bipyrazole derivatives as jak inhibitors |